Literature DB >> 15650110

Foxl1 is a mesenchymal Modifier of Min in carcinogenesis of stomach and colon.

Nathalie Perreault1, Sara D Sackett, Jonathan P Katz, Emma E Furth, Klaus H Kaestner.   

Abstract

Constitutive activation of the Wnt/APC/beta-catenin pathway is a frequent initiating event in gastrointestinal carcinogenesis. Mutations in the Adenomatous Polyposis Coli (APC) gene up-regulate Wnt signaling by stabilizing beta-catenin and causing activation of targets important in proliferation control. Here we show that loss of the mesenchymal transcription factor Foxl1 leads to a marked increase in tumor multiplicity in the colon of Apc(Min) mice. Apc(Min/+);Foxl1-/- mice also develop gastric tumors not observed in Apc(Min) mice. These effects are caused by earlier tumor initiation due to accelerated loss of heterozygosity (LOH) at the Apc locus. Foxl1 is the first mesenchymal Modifier of Min and plays a key role in gastrointestinal tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15650110      PMCID: PMC546508          DOI: 10.1101/gad.1260605

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  18 in total

Review 1.  beta-catenin signaling and cancer.

Authors:  P J Morin
Journal:  Bioessays       Date:  1999-12       Impact factor: 4.345

2.  Microadenomatous lesions involving loss of Apc heterozygosity in the colon of adult Apc(Min/+) mice.

Authors:  Yasuhiro Yamada; Kazuya Hata; Yoshinobu Hirose; Akira Hara; Shigeyuki Sugie; Toshiya Kuno; Naoki Yoshimi; Takuji Tanaka; Hideki Mori
Journal:  Cancer Res       Date:  2002-11-15       Impact factor: 12.701

3.  The Mom1AKR intestinal tumor resistance region consists of Pla2g2a and a locus distal to D4Mit64.

Authors:  R T Cormier; A Bilger; A J Lillich; R B Halberg; K H Hong; K A Gould; N Borenstein; E S Lander; W F Dove
Journal:  Oncogene       Date:  2000-06-29       Impact factor: 9.867

4.  Clustered arrangement of winged helix genes fkh-6 and MFH-1: possible implications for mesoderm development.

Authors:  K H Kaestner; S C Bleckmann; A P Monaghan; J Schlöndorff; A Mincheva; P Lichter; G Schütz
Journal:  Development       Date:  1996-06       Impact factor: 6.868

5.  Explaining variation in familial adenomatous polyposis: relationship between genotype and phenotype and evidence for modifier genes.

Authors:  M D Crabtree; I P M Tomlinson; S V Hodgson; K Neale; R K S Phillips; R S Houlston
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

6.  Canonical Wnt signals are essential for homeostasis of the intestinal epithelium.

Authors:  Daniel Pinto; Alex Gregorieff; Harry Begthel; Hans Clevers
Journal:  Genes Dev       Date:  2003-07-15       Impact factor: 11.361

7.  A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse.

Authors:  A R Moser; H C Pitot; W F Dove
Journal:  Science       Date:  1990-01-19       Impact factor: 47.728

8.  Different familial adenomatous polyposis phenotypes resulting from deletions of the entire APC exon 15.

Authors:  Li-Kuo Su; Wendy Kohlmann; Patricia A Ward; Patrick M Lynch
Journal:  Hum Genet       Date:  2002-06-14       Impact factor: 4.132

9.  Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse.

Authors:  W F Dietrich; E S Lander; J S Smith; A R Moser; K A Gould; C Luongo; N Borenstein; W Dove
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

10.  The Min (multiple intestinal neoplasia) mutation: its effect on gut epithelial cell differentiation and interaction with a modifier system.

Authors:  A R Moser; W F Dove; K A Roth; J I Gordon
Journal:  J Cell Biol       Date:  1992-03       Impact factor: 10.539

View more
  35 in total

Review 1.  The "O" class: crafting clinical care with FoxO transcription factors.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Jinling Hou; Yan Chen Shang
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

2.  Giving APCmin tumours a SPARC.

Authors:  Alex Gregorieff; Hans Clevers
Journal:  Gut       Date:  2007-04-19       Impact factor: 23.059

Review 3.  The Wnt signaling pathway: aging gracefully as a protectionist?

Authors:  Kenneth Maiese; Faqi Li; Zhao Zhong Chong; Yan Chen Shang
Journal:  Pharmacol Ther       Date:  2008-02-11       Impact factor: 12.310

4.  Somatic recombination in adult tissues: What is there to learn?

Authors:  Katarzyna Siudeja; Allison J Bardin
Journal:  Fly (Austin)       Date:  2016-11-11       Impact factor: 2.160

5.  FOXL1, a novel candidate tumor suppressor, inhibits tumor aggressiveness and predicts outcome in human pancreatic cancer.

Authors:  Geng Zhang; Peijun He; Jochen Gaedcke; B Michael Ghadimi; Thomas Ried; Harris G Yfantis; Dong H Lee; Nader Hanna; H Richard Alexander; S Perwez Hussain
Journal:  Cancer Res       Date:  2013-06-25       Impact factor: 12.701

Review 6.  Role of the Wnt/β-catenin pathway in gastric cancer: An in-depth literature review.

Authors:  Miguel Angel Chiurillo
Journal:  World J Exp Med       Date:  2015-05-20

Review 7.  A fork in the path: Developing therapeutic inroads with FoxO proteins.

Authors:  Kenneth Maiese; Jinling Hou; Zhao Zhong Chong; Yan Chen Shang
Journal:  Oxid Med Cell Longev       Date:  2009 Jul-Aug       Impact factor: 6.543

8.  FoxF1 and FoxL1 link hedgehog signaling and the control of epithelial proliferation in the developing stomach and intestine.

Authors:  Blair B Madison; Lindsay B McKenna; Diane Dolson; Douglas J Epstein; Klaus H Kaestner
Journal:  J Biol Chem       Date:  2008-12-02       Impact factor: 5.157

9.  The expanding role of mouse genetics for understanding human biology and disease.

Authors:  Duc Nguyen; Tian Xu
Journal:  Dis Model Mech       Date:  2008 Jul-Aug       Impact factor: 5.758

10.  Functional exploration of the adult ovarian granulosa cell tumor-associated somatic FOXL2 mutation p.Cys134Trp (c.402C>G).

Authors:  Bérénice A Benayoun; Sandrine Caburet; Aurélie Dipietromaria; Adrien Georges; Barbara D'Haene; P J Eswari Pandaranayaka; David L'Hôte; Anne-Laure Todeschini; Sankaran Krishnaswamy; Marc Fellous; Elfride De Baere; Reiner A Veitia
Journal:  PLoS One       Date:  2010-01-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.